NCT06147037
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06147037
Title A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Research Site WITHDRAWN Irvine California 92618 United States Details
Research Site RECRUITING Palo Alto California 94304 United States Details
Research Site NOT_YET_RECRUITING Santa Monica California 90404 United States Details
Research Site RECRUITING Chicago Illinois 60637 United States Details
Research Site RECRUITING Boston Massachusetts 02215 United States Details
Research Site WITHDRAWN St Louis Missouri 63110 United States Details
Research Site RECRUITING Omaha Nebraska 68130 United States Details
Research Site RECRUITING Cleveland Ohio 44195 United States Details
Research Site WITHDRAWN Pittsburgh Pennsylvania 15237 United States Details
Research Site RECRUITING Houston Texas 77030 United States Details
Research Site RECRUITING Seattle Washington 98109 United States Details
Research Site NOT_YET_RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
Research Site RECRUITING Halifax Nova Scotia B3H 2Y9 Canada Details
Research Site RECRUITING Montreal Quebec H2X 0A9 Canada Details
Research Site RECRUITING Sherbrooke Quebec J1H 5N4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field